Looking for a worthy cause to support? Need an excuse to enjoy the spring weather? Join our team this Saturday, March 27, as we support the National MPS Society's Virtual Raleigh Run for Rare MPS 5k Run & 1 Mile Walk. Register or donate at support.mpssocietygive.org/team/344326 #raredisease

Our latest press release: #drugrepurposing work to find molecules that could be used to treat #COVID19 patients, in collaboration with @collabchem and NC State University biology researchers. news.ncsu.edu/2021/03/antivi…

We're ready to move forward in finding therapeutics for #MPS disease-literally! Saturday our team will walk & run to support efforts of mpssociety.org as part of the Virtual Raleigh Run for Rare MPS. Find out more about our work at collaborationspharma.com/pipeline #RareDisease

TODAY Sr Scientist Dr. Ana Puhl presents her poster "Applying #MachineLearning To #DrugDiscovery At Collaborations Pharmaceuticals" at the North American Protein Degradation Congress' free mixer event - Women In Targeting The Undrugged. Register at usa-protein-degradation.com/events/north-a…

Read Dr. Ana Cristina Puhl's interview with CBS WNCW Channel 17's Judith Retana in Raleigh, NC about our #COVID19 research and findings: cbs17.com/community/heal… #sarscov2 #ebola #drugrepurposing

We're excited to announce that our new improved #drugdiscovery & #toxicology #MachineLearning software, Assay Central 2.0, is available! Learn how it can help your research efforts Thurs 4/22 at 11:30 a.m. ET (8:30 a.m. PT). Register now to save your spot zoom.us/webinar/regist…

Our latest publication "Discovery of 5-Nitro-6-thiocyanatopyrimidines as Inhibitors of Cryptococcus..." includes contributions from @collabchem PhD, DSc. Read about the findings on improving #antifungal therapies here pubs.acs.org/doi/10.1021/ac… #MachineLearning

Discover advancements while learning how our #MachineLearning software, Assay Central, can improve your business' research and testing: Learn more & register at zoom.us/webinar/regist… #toxicology #drugdiscovery #deeplearning #artificialintelligence

The necessity of #artificialintelligence to #pharma and #biotech R&D continues to increase. Join @collabchem as he chairs & presents at the #AI Driven Drug Repositioning & Repurposing Digital Summit on 4/20. Learn more & register to attend ai-driven-drug-repositioning.com #drugrepurposing

On May 20 @collabchem will present "Applying #MachineLearning to Build a Company Pipeline" and participate in a panel discussion of "AI Predictions for Efficacy and Safety." For more information and to register visit drugdiscoverychemistry.com/Artificial-Int… #artificialintelligence #drugdiscovery

THIS THURSDAY take a dive into the next generation of our #MachineLearning technology, Assay Central. See what we can do to advance your company's #drugdiscovery & #toxicology endeavors. Live presentation on 4/22 at 11:30 a.m. ET (8:30 a.m. PT). Register: zoom.us/webinar/regist…

Watch an intro to & demo of our enhanced & improved #machinelearning software, Assay Central. Find out what it can do for you & learn why we have so many repeat #pharmaceutical & #consumerproducts clients. zoom.us/rec/share/A1hB… #drugdiscovery #toxicology

Non-animal methods for assessing toxicity are more sought after today. The U.S. ICCVAM ATWG organized an international collaboration, including @collabchem, to develop in silico models to predict acute oral toxicity. Read their findings: pubmed.ncbi.nlm.nih.gov/33929906/ #toxicology #QSAR

Learn from an expert how to generate new, valid molecules that have desirable properties - such as activity against a target, low toxicity & easy synthesis - by training a neural network. Register for the free, live webinar zoom.us/webinar/regist… #MachineLearning #NeuralNetworks

#cheminformatics webinar on our de novo drug design approach to using thousands of #machinelearning models for ADME/Tox properties & bioactivity, introduce some of our work to validate generative RNN approaches & discuss application beyond small molecules. zoom.us/webinar/regist…

Join Dr. @collabchem PhD, DSc, TODAY as he presents "Applying #MachineLearning to Build a Company Pipeline" at Cambridge Healthtech Institute’s 3rd Annual Artificial Intelligence for Early Drug Discovery virtual event drugdiscoverychemistry.com/Artificial-Int… #drugdiscovery #ArtificialIntelligence

On International Batten Awareness Day Collaborations Pharmaceuticals, Inc․ was awarded a Phase II SBIR from NINDS for developing an enzyme replacement therapy for CLN1 s.einnews.com/OAl1XpfmWM

It’s a beautiful morning in Philly! Our riders are going strong at the 2022 Million Dollar Bike Ride! Thank you to everyone who is riding, donated, and fundraised helping us get to over $60,000 for Pitt Hopkins research!! #mdbr2022 #pitthopkins

Collaborations Pharmaceuticals, Inc. Awarded A Phase II SBIR award from NIEHS/NIH to Develop MegaTox® software einpresswire.com/article/584008… via صحيفة عين الأخبار

So much gratitude for Ethan Perlstein bio/acc, Ophir Klein, Tomas Wald, Jessica Lao and #UCSF team that have made this project possible. This was the first dedicated project to help find a cure for MEPAN. Regardless of outcome, we have advanced the science. Onward.